Patients with non-Hodgkin lymphoma including chronic lymphocytic leukemia (NHL/CLL) are at higher risk of severe SARS-CoV-2 infection. We investigated vaccine-induced antibody responses in patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback